Answers are grounded in this paper and cite their sources.
AZA is a modestly effective treatment for NMO. However, many patients discontinue AZA over time and this seems to reflect poor tolerability more than lack of efficacy.
No takes yet. Share an insight, caveat, or question.
Elsone et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: